Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effects of Intranasal Oxytocin on Satiety Signaling in People With Schizophrenia

This study has been completed.
Information provided by (Responsible Party):
MPRC, University of Maryland Identifier:
First received: March 20, 2012
Last updated: August 25, 2016
Last verified: August 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2014
  Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)